安全管理の基本姿勢
Contents
1. 1 22. 300 R R 3 7 25 50 30 10R 20R 30R 50R N N 300 ER R 30R 0 1 30R
3. 15 3 15 3 1 15 3 2
4. HH 2009 11 15 ECGe 2009 11 15 2009 11 15
5. 20 100mg 200 400mg 200mg 250mg 5mL 250mg 10mL 21 3 2 1 250mg 21 3 3 67 08 P P
6. 8 X P 9 10 11 12
7. 11 6 2 Tse 11 6 3 28
8. 1 2 3 4 5 4 6 7 15 5 2 1 2 3 4
9. 10 3 3 3 3 4 rt 10 3 3 1
10. 12 17 2 2 40 12 17 2 3 MR MR
11. CVC 14 6 14 7
12. 44 13 11 TI 5 13 12 ID TID 1 45 CHAPTER 14 1
13. 0 025 1mL 0 1 0 025mg 2 0 1mg 21 3 13 1 21 3 14 1A 10mL DD i 5 10A
14. 7 2 7 2 1 22 2 7 2 2 1 3a 2 2 CT 3 0 2 4 5
15. OOO O 11 8 2 OO OOO OD 11 8 3 11 9 11 9 1 29
16. 3 2 2 3 2 3 3 4 Tt Tm
17. 5 15 el mmHg mmHg 3 RE 5 6
18. 13 14 7 2 3 1 0 lt 2 3a Es 2 3
19. 77 23 4 23 5 23 4 1 CO mmF g 50 Real Time Trend LU MM 23 4 2 ul 1 Real Tirme Trend hl O OO O 7 CO2 23 4 3 Cs EMMHIY wa Real Tirne Trend CO2
20. 2 1 2 1 2 1 3 Event Report 2 1 4
21. 3 9 4 1 CHAPTER 4 2 4 3 4 4 hb
22. V 25 11 2 3 11 3 11 3 1 V MS 11 3 2 MS mitral stemosis multiple sclerosis 11 4 26 11 4 1
23. L R 11 13 2 IT 1 31 11 13 3 11 14 11 14 1
24. 16 4 1 COPD 70 COPD NYHA3 4 C
25. 80 13 4 2 2 TD Al 13 4 2 3
26. 10 3 3 2
27. Rl HH 10 3 2 1 10 3 2 2 RE 10 3 2 3
28. 4 Ko 8 mn gt HH E 18 3 18 4
29. 3 0 15 4 EUH 5 15 5 15 5 1
30. 2008 1 15 65 21 1 CHAPTER 21 2 ZE lt gt F 100mg
31. 12 9 1 12 9 2 12 9 3 37 12 10 12 10 1 12 10 2 12 10 3
32. 12 11 12 11 1 12 11 2 12 11 3 SN 12 12 12 12 1 38 12 12 2
33. 55 17 1 CHAPTER T 17 2 1 2 3 is 4 17 2 1 1
34. 2009 11 16 S 1 25 1 CHAPTER 25 2 25 3 25 2 1 4 6 25 2 2 X 8Fr 10Fr S 2 25 3 1 1 2 4 6 3
35. aii 5 1 2 3 20 5 1 8 8
36. 10 5 2 es 10 5 3
37. 2 11 5 11 4 2 11 4 3
38. 1 H A 1 FT UL lt 0 2 5mL 20mg 4mg 4mg 10mg 50mg 4 uy 50 100 21 3 14 1
39. 11 15 3 11 16 11 16 1 1 2009 11 15 1
40. 5 15 5 20 3 1 2 3
41. 11 5 2 6 a 11 5 3 ICU 27 11 6 11 7 11 6 1 1V 1U IV 1 1
42. 2 1 9 5 CHAPTER 3 1 Lr 3 2 2 3 2 1
43. S 1 IS 1 a 2008 1 15 16 1 CHAPTER 16 2 S Wh 1
44. E 4 it pl PUT 1 2 3 4 5 Cnr 6 6 4 8 4 1
45. no Rl gt 3 4 1 MSW 3 4 2 3 4 3 3 4 3 1
46. 1F 0 1F 18 7 30 1 Oo Ls uh k 41 CHAPTER ID
47. 11 14 2 MI kl 11 14 3 11 15 32 11 15 1 11 15 2
48. 2 5 48 25 30 21 3 15 ww 10mg 50mg 10mg 20mg
49. 4 5 1 4 6 3
50. MR 12 17 1 2 12 17 2 12 17 2 1 ON
51. Unknown Set 1 ID Unknown Set 12 3 XP 12 3 1 35 12 3 2 12 3 3 12 4 12 4 1 12 4 2 12 4 3 E
52. 2 5 ul S 62 20 3 1
53. 17 3 i 4 5 6 7 8 8 8
54. 8 6 2 Level 5 8 6 3 Level 4 Level 5 2 3 1 8 7 1 2
55. F 75 70 22 4 9 2009 11 17 23 1 CHAPTER 23 2 23 3 1 KW a 2 5
56. 13 1 1 2 13 2 13 2 1
57. 17 2 3 3 a 3 17 2 3 2 17 2 3 3
58. Chapter 5 3 4 3 7 3 4 4 Chapter 4 3 5 Chapter 5 3 6
59. Ne th i 17 2 2 2 17 2 2 1 El HHT E 30 E E
60. DVT PE 53 DVT PE 2 5 16 3 2 point 0 2 Low 3 4 Moderate 5 6 High 7 Highest 1 16 4
61. 7 1 4 7 1 5 1 2 3 7 1 6 MSW
62. 20 4 4 2004 E 5
63. 11 8 11 7 2 11 7 3 11 8 1
64. 1 2 3 2 22 4 Bb E gt ll 22 4 1 22 4 2
65. 12 7 2 12 7 3 XP Chapter 25 p 82 12 8 IVH 12 8 1 IVH 12 8 2 12 8 3 IVH
66. 1 2 8 4 1 2 3 8 5 8 6 8 6 1 Level 4 Level 5
67. KCL 20mEq 10mEq PK0 5 10mL 21 3 3 1 KCL 21 3 4 8 5 0 5 5mL 0 5M 20mL 2 21 3 5 10 1M 2 5M 10 20mL 21
68. 3 7 2 a 1 AM 3 8 NN
69. ww MW First do no harm CHAPTER 2 1 2 1 1 2 1 1 1 2 1 2
70. 14 9 2 14 9 1 NE 14 9 2 80 7 1
71. ICU 11 9 2 11 9 3 lt MR dl WY Sm 11 10 11 10 1 gh 2 10 I 11 10 2 2 10
72. J 22 4 4 1 1 2 3 22 4 4 2 1 2 1 1
73. 19 2 ranhya 5 4 En A DD 19 3 1 2 3 4
74. 2 1 2 24 3 A 2 MM roti
75. 15 5 3 1 2 3 4 CO E 5 6 7 7
76. PHS 6205 6106 3 SafeMaster 2010 4 1 4 5 11 CHAPTER 7 1 7 1 1 7 1 2 1 3a 2 0 2 3 2 CT
77. 6 E 14 8 2 1 47 2 Nb 3 1 3 14 8 1 2 5mm 3 2 5ml 23G 2 4
78. tr E 0 1 4 0 1 0 1 lmL L 0 02 1mL 100mg 5mL 200 100mg 21 3 1 1 3A 50mL 3 0mL hr 30 0mL hr 2 3 Bp192 92 21 3 2 10 20xg mL
79. ID Bl f 13 5 13 5 1 13 6
80. Chapter 19 p 60 18 5 ul 3 2 S 8 EE Ex 2008 1 15 FH 59 CHAPTER 19 1 CT MR
81. 2 1 5 2 1 6 2 1 7 2 1 8 5 R Right patient Right medicine Right dose Right route and Right time
82. gt 7 8 A SM 23 5 1 CHBCK 1 6 2 DD 23 5 2 or RR NN 6 B 2009 11 17 79 CHAPTER 24 1
83. rr CHAPTER 11 1 1 2 3 4 8 5 2 6 7 8 9 10 11 12
84. 1 E 2 3 7 4 3 Rp 22 4 3 22 4 4
85. 21 2 1 2 1 21 2 1 3 5 FU 21 3 21 3 1 ce
86. 50mg 10mg 10mg 10mg D XxX 0 5mg 20mg 10mg 5mg 20mg 50mg 30mg 30mg 100mg 20mg 80mg 10mg Img 3mg 10mg dose 1imiting factor 2mg 50mg 100mng 500mg 1g 1
87. 13 7 0 1 13 7 1 13 6 2 13 8 13 8 1 13 8 2 13 6 2 13 9 6 7 8 E 13 9 1 13 10
88. 8 2 2 6 2 2 1 2 PHS 6205 6106 3 SafeMaster 4 2010 4 1 15 8 3 8 2 2 1
89. NNN NO 14 2 14 3 f 0 E BS IC C E IC IC 14 4 IC 14 4 1
90. 1 2 3 8 2 3 8 2 4 1 2 3 E
91. 8 7 1 72 21 3 12 Torsades de Pointes 2 5mL 1 P 21 3 12 1 1 2A 2 100mg 1000ng 1 2A 21 3 13 1H 10
92. 11 11 3 11 12 11 12 1 2 E L R E
93. 8 9 45 7 8 8 1 8 2 1 2 8 8 2 1 2 3
94. 12 12 3 ES 12 13 12 13 1 12 13 2 12 13 3 12 14 12 14 1
95. 14 10 2 X X 2008 1 15 49 CHAPTER 15 1 15 2 15 2 1 15 2 2
96. 33 11 18 11 17 3 34 11 18 1 11 18 2 11 18 3
97. 2 3 16 2 1 A i Ne 16 3 DW TO 16 3 1 lpoint 2point 60 20
98. 12 14 2 12 14 3 3 12 15 H 12 15 1 12 15 2 12 15 3
99. 5 4 2 6 1 1 NN NA CHAPTER 6 1 1 E H 10 0 2 3a 10
100. 500mg 100mg 20 20mg 200mg N 400mg 200mg 200ng 1g 10 50mg 10mg 20mg 20mg 10mg 10mg 20mg 50mg 10mg C 2mg D
101. 2 Fi 16 6 3 1 1 nn 2 0 3 4 5 Es TT 6 GS E El 7 8 21 24 8 3 2
102. 13 14 15 16 17 7 bi 11 2 1 ID 2 ID E 11 2 2
103. CHAPTER 5 2 1 2 5 3
104. 11 5 1 0 a 5 ER 5
105. X XP 1 lt A FD dn 11 12 2 11 12 3 11 13 11 13 1
106. 21 3 10 w A 8 SU 40mg 1mg 1 25mng 2 5mg 69 BG 250mg 10mg i e GI 0D 0 3mg
107. R 12 5 12 5 1 12 5 2 12 5 3 12 6 12 6 1 12 6 2 1H 12 6 3 36 12 7 12 7 1
108. 4b 5 2010 4 1 6 6 2 1 0 3a 8 4 SafeMaster E 24 48 2010 4 1 6 2 2 3b 5 1 3b 5 Uz 2 24 5
109. 3 3 1 T ii 3 3 2 1 3 3 3 3 4
110. 0 01 0 02 0 03 1 2 3a 3b 4a
111. 3a 3b 4a 12 4b 5 2010 4 1 7 1 3
112. 4 CHAPTER 8 1 1 4 5 2 3 4 a DAE v 4b TS ks 5 8 2 2010 4 1 8 2 1
113. 10 4 Nb 2 4 10 5 10 5 1
114. 200 PL g D 1g Epp CU mt 66 S Tr 2 5 21 2 1 21 2 1 1 A ED H
115. 4 0 2 5 6 0 01 0 02 0 03 1 2
116. NS 1 I pH PT o 10 3 3 3
117. 10 3 1 1 0 10 3 1 1 2 22 10 3 1 2 a 10 3 1 3 10 3 2 2
118. OO 3 4 5 6 7 10 1 CHAPTER GT
119. 39 10L 12 16 12 16 1 12 16 2 12 16 3 XP 12 17 12 17 1 ee
120. 1 22 4 5 ll a 22 4 6 2 1 22 4 7 1 22 4 8 5
121. 10 11 10 3 11 11 30 11 11 1 11 11 2
122. 20 4 5 S 600mg 1 g 1 g 1 0 100mg 2 0 0mg 1 0 0mg 2 0 0 mg 1 0 0 mg 500mg S 1 g S 2 g 0 5g 50mg 0 2 1 00 ml 6 4 20 5
123. 5mg 10mg MS 10mg 30mg 60mg 2 5mg 5mg 5mg 10mg 20mg 40mg 0 1mg 0 5mg MT 2 1mg 4 2mg 12 6mg 16 8mg 200mg 500mg 21 3 16 100 10mg
124. CHAPTER 12 1 12 1 1 12 1 2 12 1 3 ID ID EE 12 2 12 2 1 Es 12 2 2 12 2 3
125. 4 5 6 7 18 8 10 8 10 1 O 24 8 10 2 Or 19 9 1
126. i Eg MM 1 14 4 3 3 SN
127. 1 63 2 3 L 20 4 2 1 2 15 lt gt 4m 2 15mm lt gt 20 4 3
128. 20 9 1 1 9 1 2 9 1 3 1 OO 9 1 5125 2
129. S S 4 16 4 2 16 4 2 1 35 0
130. Sp02 1 14 8 F E 14 8 1 45 Ss SOS TS KK 5mm NE E 5 2 5ml 23G
131. E dh 20 4 1 ZI 20 4 1 1 0 16
132. 0 5mg 5mg 5mg 5mg 10mg 10mg lmg 3mg 10mg 30mg 30mg 100mg 20mg 80mg 40mg 100mg S 25 100mg 400mg 21 3 11 1 10 19 PE
133. 14 9 3 X T a A 14 9 4 14 10 48 14 10 1 X
134. 13 6 1 6 2 13 6 2 1 4 3 2 TD 3 4 13 7
135. 13 3 ID 13 4 13 4 1 4 2 13 4 2 13 4 2 1
136. 24 1 1 24 1 1 1 1 OO 2 24 1 1 2 2 80 i ET 24 2 24 2 1
137. 60 19 5 2008 1 15 6 1 CHAPTER 20 1 20 2 1 2 3
138. hs HR C02 C02 C02 C02 6 4 5 BVM 6 23 3 1 XP De a a ns E
139. 10mg 2009 11 16 22 1 CHAPTER J 3 1 22 3 y H
140. 1 2 2 Vv LV 10 1 1 LE 1 2 3 10 2 4 1 2 3 4 10 3
141. 11 7 1 OX OO ml A ml A OO ml A
142. 4 5 UL 46 2 14 5 2 3
143. 3 6 1 3 6 2 3 7 3 7 1
144. K P K K WN ORIYA I NT 17 2 4 4 2008 1 15 37 CHAPTER
145. 3 4 3 2 3 4 3 3 3 4 3 lt 3 3 4 3 3 4 3 6
146. 3 6 el 100mL Mg0 5 20ml 21 3 7 ES 10 000 10mL 100 mL 10mL Na 5000 HK 21 3 7 1 5 10 000 5A 1A 5A 2
147. 5 12 18 12 18 1 6 12 18 2 12 18 3 Se D O
148. 5 19 4 Y
149. 50mg 21 3 10 1 do 9 21 3 11
150. 00mg 50mg 50mg 20mg 100mg 10mg 25mg 50mg 50mg 100mg 50mng 150mg 50mg 150mg 10mg 50mg 100mg 100mg dose 1imiting factor 5mg 50mg 200mg 500mg 5 FU 50mg 5 FU 250mg 200mg 300mg 50mg 20mg 25mg
151. 1 16 2 11 16 3 Chapter 24 p 80 11 17 11 17 1 ADL 11 17 2
152. 1 3 8 R 4 E KK Img 5mg E gt 21 3 8 1 gt SM es 21 3 9
153. CHAPTER 1 1 Patient Safety Action PSA PSA
154. OD 13 H 2009 11 16 8 3 84
Download Pdf Manuals
Related Search